Sign in

or Register now

MyDepressionConnection.com

See all of our health sites at www.HealthCentral.com
Saturday, October 11, 2008

Glaucoma vision loss leads to more health problems

Tuesday, Jun. 10, 2008; 3:27 AM

NEW YORK (Reuters Health) - A new study of Medicare beneficiaries with glaucoma demonstrates that vision loss is associated with a greater risk of depression, nursing home admission, and femur fracture.

Care became more costly as vision worsened, Dr. Thomas Bramley of Xcenda in Salt Lake City and colleagues also found, ranging from $8,157 for patients with no vision loss to $18,670 for those with complete blindness.

Glaucoma accounts for about three quarters of all cases of visual impairment, Bramley and his team note in their report. Recently, they add, Medicare has been emphasizing awareness of glaucoma and progression of the disease.

To better understand the economic impact of the adverse consequences of vision loss in people with glaucoma, the researchers looked at a nationally representative sample including 5 percent of all Medicare patients.

Their analysis included 181,922 people diagnosed with glaucoma between 1999 and 2004; of these subjects, 92.1 percent had no vision loss. Another 4.3 percent were classified as having moderate vision loss, 1.9 percent had severe vision loss, and 1.7 percent were blind.

The risk of all adverse events that the researchers looked at rose as vision worsened. Patients with any degree of vision loss were more than twice as likely as those with intact vision to be placed in a nursing home. Patients who vision loss were also 63 percent more likely to develop depression, 67.4 percent more likely to sustain a femur fracture, and 58.6 percent more likely to suffer a fall or accident.

"Results from this study showed that as visual field limitations increased, resource consumption, adverse consequences, and intensity of care also increased," the researchers write. Inpatient care was the main factor driving the increased costs, they found.

SOURCE: Archives of Ophthalmology, June 2008.


Copyright © 2008 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Ask a Question

Get answers from our experts and community members.

Answer a Question

I have been taking prozac for 3 months and I am concerned about some of the side effects

Answer This View all questions >
Free Newsletter
Get weekly updates, news alerts and more on Depression and related health conditions.